Caterina Cinti
Geciteerd door
Geciteerd door
Ras family genes: an interesting link between cell cycle and cancer
M Macaluso, G Russo, C Cinti, V Bazan, N Gebbia, A Russo
Journal of cellular physiology 192 (2), 125-130, 2002
Mutations in the retinoblastoma-related gene RB2/p130 in lung tumors and suppression of tumor growth in vivo by retrovirus-mediated gene transfer
PP Claudio, CM Howard, C Pacilio, C Cinti, G Romano, C Minimo, ...
Cancer research 60 (2), 372-382, 2000
Exposure to 900 MHz electromagnetic field induces an unbalance between pro‐apoptotic and pro‐survival signals in T‐lymphoblastoid leukemia CCRF‐CEM cells
F Marinelli, D La Sala, G Cicciotti, L Cattini, C Trimarchi, S Putti, ...
Journal of cellular physiology 198 (2), 324-332, 2004
Differential expression of Rb2/p130 and p107 in normal human tissues and in primary lung cancer.
A Baldi, V Esposito, A De Luca, Y Fu, I Meoli, GG Giordano, M Caputi, ...
Clinical Cancer Research 3 (10), 1691-1697, 1997
pRb2/p130-E2F4/5-HDAC1-SUV39H1-p300 and pRb2/p130-E2F4/5-HDAC1-SUV39H1-DNMT1 multimolecular complexes mediate the transcription of estrogen receptor-α in breast cancer
M Macaluso, C Cinti, G Russo, A Russo, A Giordano
Oncogene 22 (23), 3511-3517, 2003
Multiple genetic and epigenetic interacting mechanisms contribute to clonally selection of drug‐resistant tumors: current views and new therapeutic prospective
A Roberti, DL Sala, C Cinti
Journal of cellular physiology 207 (3), 571-581, 2006
Genetic alterations disrupting the nuclear localization of the retinoblastoma-related gene RB2/p130 in human tumor cell lines and primary tumors
C Cinti, PP Claudio, CM Howard, LM Neri, Y Fu, L Leoncini, GM Tosi, ...
Cancer research 60 (2), 383-389, 2000
Mutations in the retinoblastoma-related gene RB2/p130 in primary nasopharyngeal carcinoma
PP Claudio, CM Howard, Y Fu, C Cinti, L Califano, P Micheli, EW Mercer, ...
Cancer research 60 (1), 8-12, 2000
Genetic alterations of the retinoblastoma-related gene RB2/p130 identify different pathogenetic mechanisms in and among Burkitt's lymphoma subtypes
C Cinti, L Leoncini, A Nyongo, F Ferrari, S Lazzi, C Bellan, R Vatti, ...
The American journal of pathology 156 (3), 751-760, 2000
Modulation of cell cycle components by epigenetic and genetic events
M Macaluso, M Montanari, C Cinti, A Giordano
Seminars in oncology 32 (5), 452-457, 2005
Interleukin 1 alpha stimulates nuclear phospholipase C in human osteosarcoma SaOS-2 cells.
S Marmiroli, A Ognibene, A Bavelloni, C Cinti, L Cocco, NM Maraldi
Journal of Biological Chemistry 269 (1), 13-16, 1994
Searching for the perfect wave: the effect of radiofrequency electromagnetic fields on cells
L Gherardini, G Ciuti, S Tognarelli, C Cinti
International journal of molecular sciences 15 (4), 5366-5387, 2014
IMP dehydrogenase inhibitor, tiazofurin, induces apoptosis in K562 human erythroleukemia cells
M Vitale, L Zamai, E Falcieri, G Zauli, P Gobbi, S Santi, C Cinti, G Weber
Cytometry: The Journal of the International Society for Analytical Cytology …, 1997
Activated Akt as an indicator of prognosis in gastric cancer
C Cinti, C Vindigni, A Zamparelli, D La Sala, MC Epistolato, D Marrelli, ...
Virchows Archiv 453 (5), 449-455, 2008
The behaviour of nuclear domains in the course of apoptosis
A Cataldi, C Cinti, S Santi, D Bosco, M Vitale, L Zamai, P Gobbi, C Betts, ...
Histochemistry 102 (3), 221-231, 1994
Interaction between HIV-1 Tat and pRb2/p130: a possible mechanism in the pathogenesis of AIDS-related neoplasms
G De Falco, C Bellan, S Lazzi, PP Claudio, D La Sala, C Cinti, P Tosi, ...
Oncogene 22 (40), 6214-6219, 2003
Newly engineered magnetic erythrocytes for sustained and targeted delivery of anti-cancer therapeutic compounds
C Cinti, M Taranta, I Naldi, S Grimaldi
PloS one 6 (2), e17132, 2011
Nuclear matrix-bound replicational sites detected in situ by 5-bromodeoxyuridine
LM Neri, G Mazzotti, S Capitani, NM Maraldi, C Cinti, N Baldini, R Rana, ...
Histochemistry 98 (1), 19-32, 1992
A morphologic approach to detect apoptosis based on electron microscopy
MK White, C Cinti
Cell Cycle Control and Dysregulation Protocols, 105-111, 2004
Combinatorial treatment of DNA and chromatin-modifying drugs cause cell death in human and canine osteosarcoma cell lines
V Thayanithy, CW Park, AL Sarver, RV Kartha, DM Korpela, AJ Graef, ...
PloS one 7 (9), e43720, 2012
Het systeem kan de bewerking nu niet uitvoeren. Probeer het later opnieuw.
Artikelen 1–20